Oral Anticoagulation in Hemodialysis
NCT03799822
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
132
Enrollment
OTHER
Sponsor class
Conditions
Atrial Fibrillation
Interventions
DRUG:
Rivaroxaban 10 MG Oral Tablet
DIETARY_SUPPLEMENT:
MK-7 2000µg thrice weekly
DRUG:
Vitamin K Antagonist - Drug
Sponsor
Onze Lieve Vrouw Hospital